Teva Pharmaceutical snaps six straight sessions of losses
Teva Pharmaceutical ( NYSE: TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 ...
Unusually active option classes on open February 6th
Unusual total active option classes on open include: Altus Power ( AMPS ), nVent Electric ( NVT ), Teva (TEVA), Peloton Interactive ( PTON ), Huntington Bancshares ( HBAN ), Tapestry ( TPR ), Philip ...
3 Generic Drug Stocks to Watch
The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...
Specialty Generics Growth Trends and Business Opportunities, 2025-2033: Patent Expirations of Branded Drugs a Key Driver
Teva Pharmaceuticals Industries, Akorn Inc., Mylan N.V., Mallinckrodt, and Sandoz International GmbH Lead the Competition ...